Literature DB >> 22733270

Diabetes: insulin plus metformin for T2DM--are there benefits?

Clifford J Bailey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22733270     DOI： 10.1038/nrendo.2012.106

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes.

Authors:  J A Johnson; S H Simpson; E L Toth; S R Majumdar
Journal:  Diabet Med       Date:  2005-04       Impact factor: 4.359

Review 3.  Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.

Authors:  Bianca Hemmingsen; Louise Lundby Christensen; Jørn Wetterslev; Allan Vaag; Christian Gluud; Søren S Lund; Thomas Almdal
Journal:  BMJ       Date:  2012-04-19

Review 4.  Metformin: effects on micro and macrovascular complications in type 2 diabetes.

Authors:  Clifford J Bailey
Journal:  Cardiovasc Drugs Ther       Date:  2008-02-21       Impact factor: 3.727

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 7.  AMPK: an emerging drug target for diabetes and the metabolic syndrome.

Authors:  Bei B Zhang; Gaochao Zhou; Cai Li
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

8.  Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.

Authors:  Adriaan Kooy; Jolien de Jager; Philippe Lehert; Daniël Bets; Michiel G Wulffelé; Ab J M Donker; Coen D A Stehouwer
Journal:  Arch Intern Med       Date:  2009-03-23

9.  Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Authors:  Jay S Skyler; Richard Bergenstal; Robert O Bonow; John Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin
Journal:  Diabetes Care       Date:  2008-12-17       Impact factor: 17.152
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.